Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
QIFENG
873169
5
LAISAI LASER
871263
CN Stock MarketDetailed Quotes
300147 Xiangxue Pharmaceutical
- 7.37
- +0.59+8.70%
Market Closed May 9 15:00 CST
4.87BMarket Cap-5.35P/E (TTM)
7.93High6.73Low474.41KlotVolume6.78Open6.78Pre Close349.10MTurnover7.22%Turnover RatioLossP/E (Static)661.28MShares16.4952wk High5.04P/B4.85BFloat Cap3.1652wk Low8.14Limit Up657.46MShs Float41.78Historical High5.42Limit Down17.70%Amplitude3.00Historical Low--Dividend TTM7.36Avg Price212.00KlotAsk--Div YieldTTM100Lot Size244.85KlotBid
Xiangxue Pharmaceutical Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -50.95%57.52M | -11.77%131.74M | -42.27%75.6M | -19.70%102.35M | -17.99%117.27M | -10.32%149.32M | -21.56%130.96M | -40.93%127.45M | -59.93%142.99M | -15.10%166.5M |
| Transactional financial assets | ---- | ---- | ---- | ---- | 7,158.71%4M | ---- | ---- | ---- | -99.91%55.11K | -99.81%125.98K |
| Notes receivable and accounts receivable | 15.45%960.74M | 5.38%836.48M | 10.89%891.32M | 10.98%862.15M | 13.41%832.14M | 16.45%793.8M | 46.85%803.78M | -31.13%776.82M | -37.00%733.77M | -38.54%681.65M |
| -Notes receivable | -39.73%52.71M | -70.35%26.35M | -73.72%39.76M | -66.29%48.7M | -33.32%87.45M | 8.81%88.86M | 5,546.15%151.28M | 1,149.32%144.47M | --131.16M | 555.27%81.66M |
| -Accounts receivable | 21.93%908.04M | 14.92%810.13M | 30.51%851.57M | 28.64%813.45M | 23.58%744.69M | 17.49%704.94M | 19.80%652.5M | -43.36%632.35M | -48.26%602.61M | -45.29%599.99M |
| Other receivables (including interest and dividends) | 10.45%57.2M | 9.49%57.53M | 19.75%64.91M | 7.21%59.55M | -20.76%51.78M | -31.28%52.55M | -23.80%54.21M | 22.38%55.55M | -15.14%65.35M | -77.90%76.47M |
| -Dividend receivable | 0.00%22.44M | 0.00%22.44M | --22.44M | --22.44M | --22.44M | --22.44M | ---- | ---- | ---- | ---- |
| -Accrued interest receivable | --736.82K | --701.98K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other receivable | --34.02M | 14.22%34.39M | ---- | --37.11M | ---- | --30.11M | ---- | ---- | ---- | ---- |
| Advance payment | -24.75%20.47M | -60.14%9.78M | -4.51%21.63M | -26.83%21.78M | -30.12%27.21M | -55.08%24.55M | -54.42%22.65M | 8.09%29.77M | -59.42%38.93M | -28.10%54.66M |
| Inventories | -23.60%311.39M | -17.11%340.92M | -16.63%420.98M | -5.75%462.58M | -19.71%407.6M | -11.94%411.3M | 18.25%504.96M | -27.25%490.78M | -28.45%507.63M | -38.66%467.07M |
| Receivable financing | --1.09M | 1,105.50%7.75M | ---- | --0 | ---- | -96.79%642.66K | -95.45%2.34M | -88.37%7.9M | -90.06%8.04M | -81.98%20.05M |
| Assets held for sale | -64.73%109.88M | -61.81%123.65M | 8.07%314.7M | 251.06%312.78M | 168.80%311.56M | 133.79%323.74M | 128.40%291.2M | -12.36%89.1M | 8.99%115.91M | -30.39%138.48M |
| Non-current assets due within one year | ---- | --13M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other current assets | 15.11%83.13M | 19.57%81.84M | -12.90%68.42M | -14.54%68.48M | -17.84%72.22M | -22.38%68.45M | -11.26%78.55M | -70.47%80.12M | -64.74%87.9M | -60.16%88.18M |
| Total current assets | -12.19%1.6B | -12.15%1.6B | -1.65%1.86B | 14.01%1.89B | 7.24%1.82B | 7.75%1.82B | 23.45%1.89B | -36.45%1.66B | -41.34%1.7B | -45.13%1.69B |
| Non Current assets | ||||||||||
| Other equity investment | -30.29%60.32M | -30.29%60.32M | -2.76%86.53M | -2.76%86.53M | -2.76%86.53M | -2.76%86.53M | -10.10%88.98M | -10.10%88.98M | -10.10%88.98M | -10.10%88.98M |
| Other non-current financial assets | -35.58%31.1M | -37.69%30.06M | -36.25%29.29M | -18.50%38.58M | 1.97%48.27M | 1.89%48.24M | -14.69%45.95M | -13.96%47.33M | -15.39%47.34M | -16.10%47.35M |
| Investment real estate | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Long-term equity investment | -25.59%32.87M | -24.35%33.06M | -68.32%33.92M | -88.97%34.03M | -86.87%44.18M | -86.98%43.71M | -67.52%107.08M | 178.97%308.47M | 201.41%336.38M | 192.43%335.7M |
| Fixed assets | ---- | ---- | ---- | --3.28B | ---- | --3.37B | ---- | ---- | ---- | ---- |
| Constru in process | ---- | ---- | ---- | --1.13B | ---- | --1.21B | ---- | ---- | ---- | ---- |
| Productive biological assets | 5.07%640.14K | 12.15%628.7K | 14.64%616.77K | -3.87%648.91K | -3.04%609.25K | -3.24%560.59K | 1.41%538K | -17.83%675K | -22.08%628.35K | -27.05%579.35K |
| Intangible assets | -8.62%829.18M | -8.58%840.4M | -8.33%851.89M | -7.69%868.69M | -4.67%907.42M | -4.65%919.28M | -4.70%929.27M | -6.92%941.05M | -7.54%951.92M | -6.79%964.09M |
| Development expenditure | -49.44%225.25M | -49.72%219.47M | 8.66%459.2M | 8.32%450.44M | 8.83%445.5M | 8.33%436.49M | 7.79%422.59M | 0.85%415.85M | 0.92%409.34M | 1.89%402.93M |
| Goodwill | 0.00%199.72M | 0.00%199.72M | 0.00%199.72M | 0.00%199.72M | 0.00%199.72M | 0.00%199.72M | 0.00%199.72M | -25.09%199.72M | -25.09%199.72M | -25.09%199.72M |
| Long deferred expense | -27.38%27.73M | -27.19%29.35M | -8.51%34.2M | -3.73%36.45M | 2.80%38.19M | 6.86%40.31M | 9.38%37.38M | 28.62%37.86M | 18.03%37.15M | 10.76%37.72M |
| Deferred tax assets | -26.19%21.2M | -30.81%19.66M | -5.12%25.21M | -0.34%28.4M | 8.94%28.72M | 8.02%28.42M | 74.71%26.57M | 58.43%28.5M | 36.59%26.37M | 35.79%26.31M |
| Usufruct assets | -16.21%29.62M | -15.17%30.68M | 36.45%31.91M | 39.86%33.94M | 39.31%35.35M | 36.55%36.16M | 1,313.63%23.39M | 529.46%24.27M | 458.67%25.38M | 399.97%26.48M |
| Other non current assets | 415.30%200.3M | 515.96%203.74M | -30.31%23.76M | 11.90%38.48M | 31.86%38.87M | 6.87%33.08M | -56.13%34.1M | -60.70%34.39M | -53.26%29.48M | -55.45%30.95M |
| Total non current assets | -8.95%5.84B | -8.68%5.9B | -5.83%6.2B | -8.91%6.23B | -7.03%6.42B | -6.99%6.46B | -15.69%6.58B | -17.97%6.84B | -16.56%6.9B | -8.70%6.94B |
| Total assets | -9.67%7.44B | -9.45%7.5B | -4.90%8.05B | -4.44%8.12B | -4.21%8.24B | -4.10%8.28B | -9.27%8.47B | -22.37%8.49B | -22.99%8.6B | -19.22%8.63B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -7.98%1.37B | -9.54%1.36B | -4.45%1.44B | -3.58%1.45B | -24.49%1.49B | -22.22%1.5B | -18.37%1.51B | -39.25%1.51B | -21.52%1.98B | -21.90%1.93B |
| Notes payable and accounts payable | 3.40%1.14B | 6.13%1.15B | 11.68%1.17B | 13.86%1.17B | 9.31%1.1B | 9.94%1.09B | 40.35%1.05B | 7.38%1.03B | -2.59%1.01B | -23.92%988.95M |
| -Notes payable | ---- | ---- | -97.19%258.23K | -94.68%570.63K | -95.76%518.22K | -86.17%2.48M | 167.95%9.19M | 1,686.76%10.73M | 13.28%12.21M | 85.21%17.95M |
| -Accounts payable | 3.45%1.14B | 6.37%1.15B | 12.64%1.17B | 15.00%1.17B | 10.59%1.1B | 11.72%1.08B | 39.76%1.04B | 6.32%1.02B | -2.76%996.23M | -24.74%971M |
| Contract liabilities | 14.74%158.69M | -5.40%152.53M | 49.05%151.95M | 10.07%138.98M | -21.17%138.3M | -35.24%161.24M | 35.17%101.95M | 49.43%126.27M | 139.15%175.43M | 112.11%248.99M |
| Advance receipts | --0 | -73.84%409.68K | ---- | --0 | --0 | 96.21%1.57M | ---- | ---- | ---- | --798.17K |
| Salaries payable | 78.60%59.99M | 25.85%56.05M | -7.90%39.12M | -12.86%34M | -7.89%33.59M | 29.93%44.54M | 27.88%42.48M | 12.51%39.02M | 26.16%36.47M | -1.86%34.28M |
| Taxs payable | 7.87%71.91M | 8.21%76.42M | -6.99%53.12M | -0.12%50.29M | 93.19%66.66M | 110.22%70.63M | 121.02%57.11M | 97.21%50.35M | 29.79%34.5M | 5.17%33.6M |
| Other payable (including interest and dividends) | 21.28%2.26B | 19.78%2.23B | 8.05%1.95B | 10.82%1.93B | 6.61%1.87B | 3.33%1.86B | -28.05%1.8B | -32.33%1.75B | -32.01%1.75B | -2.53%1.8B |
| -Interest payable | --128.9M | --99.33M | --71.51M | --41.04M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Dividend payable | ---- | ---- | ---- | ---- | ---- | --15M | ---- | ---- | ---- | ---- |
| -Other payable | ---- | ---- | ---- | --1.89B | ---- | --1.85B | ---- | ---- | ---- | ---- |
| Hold and for sell liabilities | 5.39%31.57M | 11.55%29.24M | -10.47%31.55M | -5.13%31.33M | -7.97%29.96M | -29.99%26.21M | 3.69%35.24M | -9.00%33.02M | -20.92%32.55M | -57.84%37.43M |
| Non current liabilities due within one year | 87.73%644.57M | -16.75%286.33M | 135.18%277.83M | 133.67%365.04M | 335.04%343.34M | 330.08%343.95M | -49.44%118.13M | -47.23%156.22M | -76.92%78.92M | -82.25%79.97M |
| Other current liabilities | -58.88%31.92M | -37.39%41.12M | -52.09%41.12M | -52.51%45.25M | -13.76%77.64M | -18.40%65.68M | 963.21%85.83M | 978.50%95.27M | 904.16%90.02M | 426.71%80.49M |
| Total current liabilities | 12.12%5.78B | 4.27%5.38B | 7.38%5.16B | 9.25%5.22B | -0.64%5.15B | -1.37%5.16B | -12.87%4.8B | -26.48%4.78B | -22.05%5.19B | -17.64%5.23B |
| Current liabilities | ||||||||||
| Long term loan | -63.19%201.45M | 2.63%570.64M | -29.05%578.49M | -36.84%492.89M | 28.26%547.27M | 30.23%556M | 59.97%815.39M | 43.20%780.44M | -30.77%426.68M | -19.28%426.93M |
| Long term account payable | ---- | ---- | ---- | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
| Specific account payable | ---- | ---- | ---- | --75.51M | ---- | --117.15M | ---- | ---- | ---- | ---- |
| Estimate liabilities | -84.99%4.32M | -84.45%4.32M | -64.04%23.09M | -53.75%27.43M | -43.89%28.78M | -44.03%27.78M | 43.36%64.22M | 32.38%59.3M | 209.33%51.29M | 199.33%49.63M |
| Deferred tax liabilities | -13.63%8.17M | -14.21%8.12M | --8.84M | --9.25M | --9.46M | --9.46M | ---- | ---- | ---- | ---- |
| Long term deferred income | -13.09%52.96M | -11.99%53.18M | 2.78%61.04M | 0.00%60.42M | -3.63%60.94M | 0.12%60.42M | -2.42%59.39M | -8.86%60.41M | 13.62%63.23M | -8.07%60.35M |
| Lease liabilities | -5.95%30.37M | -11.58%30.88M | 162.26%33.9M | 46.16%33.81M | 44.56%32.29M | 40.13%34.92M | 1,361.56%12.93M | 1,270.10%23.13M | 882.14%22.34M | 956.45%24.92M |
| Other non current liabilities | --0 | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total non current liabilities | -61.67%307.7M | -15.91%677.55M | -27.81%780.87M | -33.60%699.31M | 15.82%802.68M | 18.10%805.73M | 44.89%1.08B | 33.77%1.05B | -13.57%693.07M | 0.55%682.26M |
| Total liabilities | 2.18%6.08B | 1.54%6.06B | 0.91%5.94B | 1.52%5.92B | 1.30%5.96B | 0.88%5.97B | -5.98%5.88B | -19.97%5.83B | -21.14%5.88B | -15.89%5.92B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%661.28M | 0.00%661.28M | 0.00%661.28M | 0.00%661.28M | 0.00%661.28M | 0.00%661.28M | 0.00%661.28M | 0.00%661.28M | -0.01%661.28M | -0.01%661.28M |
| Capital reserve funds | 0.00%2.15B | 0.00%2.15B | 0.00%2.15B | 0.00%2.15B | 0.00%2.15B | 0.00%2.15B | 0.00%2.15B | 0.00%2.15B | -0.01%2.15B | -0.01%2.15B |
| Surplus reserve funds | 0.00%105.37M | 0.00%105.37M | 0.00%105.37M | 0.00%105.37M | 0.00%105.37M | 0.00%105.37M | 0.00%105.37M | 0.00%105.37M | 0.00%105.37M | 0.00%105.37M |
| Retained profit | -88.06%-1.92B | -85.96%-1.84B | -61.82%-1.21B | -68.89%-1.12B | -72.19%-1.02B | -64.92%-987.43M | -180.40%-744.79M | -383.72%-664.71M | -2,684.58%-594.18M | -775.16%-598.72M |
| Less:Treasury stock | 0.00%8.5M | 0.00%8.5M | 0.00%8.5M | 0.00%8.5M | 0.00%8.5M | 0.00%8.5M | 0.00%8.5M | 0.00%8.5M | -3.12%8.5M | -3.12%8.5M |
| Other composite income | -1,238.90%-19.33M | -1,239.02%-19.28M | 120.44%1.63M | 122.70%1.79M | 117.72%1.7M | 132.60%1.69M | -311.36%-7.96M | -389.91%-7.9M | -600.37%-9.58M | -351.09%-5.19M |
| Shareholders equity without minority interests | -48.80%967.12M | -45.19%1.05B | -20.90%1.71B | -20.03%1.79B | -18.11%1.89B | -16.55%1.92B | -18.53%2.16B | -19.38%2.24B | -20.21%2.31B | -18.90%2.31B |
| Minority interests | -1.10%391.59M | -1.18%383.93M | -4.07%409.84M | -4.13%403.28M | -5.00%395.97M | -5.94%388.52M | -0.11%427.23M | -51.89%420.65M | -49.46%416.79M | -49.15%413.05M |
| Total shareholder equity | -40.54%1.36B | -37.80%1.44B | -18.11%2.12B | -17.51%2.19B | -16.10%2.29B | -14.94%2.31B | -15.97%2.58B | -27.17%2.66B | -26.70%2.72B | -25.62%2.72B |
| Total liabilityies and equity | -9.67%7.44B | -9.45%7.5B | -4.90%8.05B | -4.44%8.12B | -4.21%8.24B | -4.10%8.28B | -9.27%8.47B | -22.37%8.49B | -22.99%8.6B | -19.22%8.63B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Reservations with explanatory notes | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Beijing Dehao International Accounting Firm (Special General Partnership) | -- | -- | -- | Beijing Dahua International Accounting Firm (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting